EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Prophylactic Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement

Quentin Fischer, Luis Nombela-Franco, Guillem Muntané-Carol, Gabriela Veiga, Ander Regueiro, Tamim Nazif, Vicenç Serra, Lluis Asmarats, Henrique B Ribeiro, Azeem Latib, Anthony Poulin, Asim N Cheema und 15 weitere

JACC: Clinical Electrophysiology · 2025-11 · 11 (11) · 2484-2492

DOI: 10.1016/j.jacep.2025.07.028 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025-11. Verfasst von Quentin Fischer und 26 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Postoperative Complications, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Université Laval.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The management of patients developing new conduction disturbances after transcatheter aortic valve replacement (TAVR) remains largely debated. OBJECTIVES: The purpose of this study was to evaluate the incidence and clinical impact of prophylactic permanent pacemaker implantation (PPI) after TAVR. METHODS: This was a prespecified subanalysis of the PROMOTE (PRospective Application of a Pre-Specified Scientific Expert Panel AlgOrithm for the Management of COnduction Disturbances Following Transcatheter Aortic Valve Replacement) trial, a prospective multicenter study including 2,110 consecutive patients without prior pacemaker undergoing TAVR. Prophylactic PPI was considered in case of enlarged QRS with active electrocardiogram changes (daily PR or QRS interval increase ≥20 ms during 2 consecutive days), or new-onset persistent with either QRS>150 ms or PR >240 ms. RESULTS: A total of 329 patients with PPI post-TAVR were included, 80 (24.3%) of which had a prophylactic indication. The main indication (90%) of prophylactic PPI was new-onset persistent left bundle branch block with QRS >150 ms and/or PR >240 ms. The 30-day clinical outcomes were similar in prophylactic and nonprophylactic PPI patients, but the median rate of ventricular pacing percentage was significantly lower in the prophylactic PPI group (2% vs 73%; P < 0.001), with a higher rate of patients with ventricular pacing percentage

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pacemaker, ArtificialPostoperative ComplicationsTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMaleElectrocardiographyProspective Studies

Stichwörter der Autor:innen

conduction disturbancesleft bundle branch blockpermanent pacemakersudden cardiac deathtranscatheter aortic valve implantation

Autor:innen und Institutionen

  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos, Madrid, Spain.
  • Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Columbia University Irving Medical Center, New York, New York, USA.

Förderung

  • Université Laval

Zitieren

APA

Fischer, Q., Nombela-Franco, L., Muntané-Carol, G., Veiga, G., Regueiro, A., Nazif, T., Serra, V., Asmarats, L., Ribeiro, H. B., Latib, A., Poulin, A., Cheema, A. N., Tirado-Conte, G., Gomez-Hospital, J. A., Gil Ongay, A., Gabani, R., Arzamendi, D., Brener, M., Calabuig, A., …, & Rodés-Cabau, J. (2025). Prophylactic Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC: Clinical Electrophysiology, 11(11), 2484-2492. https://doi.org/10.1016/j.jacep.2025.07.028

Vancouver

Fischer Q, Nombela-Franco L, Muntané-Carol G, Veiga G, Regueiro A, Nazif T, et al. Prophylactic Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC: Clinical Electrophysiology. 2025;11(11):2484-2492. doi:10.1016/j.jacep.2025.07.028

BibTeX
@article{Fischer2025,
  author = {Fischer, Quentin and Nombela-Franco, Luis and Muntané-Carol, Guillem and Veiga, Gabriela and Regueiro, Ander and Nazif, Tamim and Serra, Vicenç and Asmarats, Lluis and Ribeiro, Henrique B and Latib, Azeem and Poulin, Anthony and Cheema, Asim N and Tirado-Conte, Gabriela and Gomez-Hospital, Joan Antoni and Gil Ongay, Aritz and Gabani, Rami and Arzamendi, Dabit and Brener, Michael and Calabuig, Alvaro and Scotti, Andrea and Gelain, Marco Antonio S and Labinaz, Marino and Cepas-Guillén, Pedro and Côté, Mélanie and Del Portillo, Juan H and Philippon, François and Rodés-Cabau, Josep},
  title = {Prophylactic Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement},
  journal = {JACC: Clinical Electrophysiology},
  year = {2025},
  volume = {11},
  number = {11},
  pages = {2484--2492},
  doi = {10.1016/j.jacep.2025.07.028}
}
Kostenlos starten →